4BB — 4Basebio Cashflow Statement
0.000.00%
Last trade - 00:00
- £138.30m
- £141.61m
- £0.27m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.423 | -0.719 | -3.23 | -5.15 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | -0.059 | 0.122 | -0.28 | -0.554 |
Other Non-Cash Items | ||||
Changes in Working Capital | -0.038 | -0.702 | 0.455 | 0.569 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Accounts Payable | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -0.269 | -1.02 | -2.74 | -4.7 |
Capital Expenditures | -0.203 | -0.849 | -1.51 | -1.94 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 0 | 2.29 | 0 | — |
Sale of Business | ||||
Cash from Investing Activities | -0.203 | 1.45 | -1.51 | -1.94 |
Financing Cash Flow Items | 0.524 | 14.5 | -0.407 | 1.32 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.487 | 14.4 | -0.467 | 1.24 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.011 | 14.9 | -5.42 | -5.24 |